STADA Arzneimittel AG

  • WKN: 725180
  • ISIN: DE0007251803
  • Land: Deutschland

Nachricht vom 14.02.2018 | 11:05

STADA Arzneimittel AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STADA Arzneimittel AG

14.02.2018 / 11:05
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany

2. Reason for notification
X Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Name: City and country of registered office:
Bank of America Corporation Wilmington, DE
United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
N/A

5. Date on which threshold was crossed or reached:
07 Feb 2018

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
total of both in %
(7.a. + 7.b.)
total number of voting rights of issuer
Resulting situation 0.0003 % 0.001 % 0.001 % 62,342,440
Previous notification 1.98 % 8.93 % 10.92 % /

7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
ISIN absolute in %
  direct
(Sec. 33 WpHG)
indirect
(Sec. 34 WpHG)
direct
(Sec. 33 WpHG)
indirect
(Sec. 34 WpHG)
DE0007251803 0 186 0.00 % 0.0003 %
Total 186 0.0003 %

b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
Right of Use N/A N/A 588 0.001 %
    Total 588 0.001 %

b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
%
      Total %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more)
Bank of America Corporation % % %
NB Holdings Corporation % % %
BofAML Jersey Holdings Limited % % %
BofAML EMEA Holdings 2 Limited % % %
ML UK Capital Holdings Limited % % %
Merrill Lynch International % % %
 
Bank of America Corporation % % %
NB Holdings Corporation % % %
BAC North America Holding Company % % %
Merrill Lynch, Pierce, Fenner & Smith Incorporated % % %
 
Bank of America Corporation % % %
NB Holdings Corporation % % %
BAC North America Holding Company % % %
Merrill Lynch, Pierce, Fenner & Smith Incorporated % % %
Merrill Lynch Professional Clearing Corp. % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG

Date of general meeting:
Holding position after general meeting: % (equals voting rights)

10. Other explanatory remarks:
 



14.02.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this